This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Knobler R, Berlin G, Calzavara-Pinton P, Greinix H, Jaksch P, Laroche L et al. Guidelines on the use of extracorporeal photopheresis. J Eur Acad Dermatol Venereol 2014; 28: 1–37.
Rutella S, Valentini CG, Ceccarelli S, Romano MT, Brescia LP, Milano GM et al. Extracorporeal photopheresis for paediatric patients experiencing graft-versus-host disease (GVHD). Transfus Apher Sci 2014; 50: 340–348.
Hart JW, Shiue LH, Shpall EJ, Alousi AM . Extracorporeal photopheresis in the treatment of graft-versus-host disease: evidence and opinion. Ther Adv Hematol 2013; 4: 320–334.
Merlin E, Hannani D, Veyrat-Masson R, Chassagne J, Gabert F, Berger M et al. Cryopreservation of mononuclear cells before extracorporeal photochemotherapy does not impair their anti-proliferative capabilities. Cytotherapy 2011; 13: 248–255.
Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus conference on acute GvHD grading. Bone Marrow Transplant 1995; 15: 825–828.
Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945–956.
Maeda A, Schwarz A, Bullinger A, Morita A, Peritt D, Schwarz T . Experimental extracorporeal photopheresis inhibits the sensitization and effector phases of contact hypersensitivity via two mechanisms: generation of IL-10 and induction of regulatory T cells. J Immunol 2008; 181: 5956–5962.
Berger M, Albiani R, Sini B, Fagioli F . Extracorporeal photopheresis for graft-versus-host disease: the role of patient, transplant, and classification criteria and hematologic values on outcome-results from a large single-center study. Transfusion 2015; 55: 736–747.
Hackstein H, Amoros JJV, Bein G, Woessmann W . Successful use of miniphotopheresis for the treatment of graft-versus-host disease. Transfusion 2014; 54: 2022–2027.
Abu-Dalle I, Reljic T, Nishihori T, Antar A, Bazarbachi A, Djulbegovic B et al. Extracorporeal photopheresis in steroid-refractory acute or chronic graft-versus-host disease: results of a systematic review of prospective studies. Biol Blood Marrow Transplant 2014; 20: 1677–1686.
Hautmann AH, Wolff D, Hahn J, Edinger M, Schirmer N, Ammer J et al. Extracorporeal photopheresis in 62 patients with acute and chronic GVHD: results of treatment with the COBE Spectra System. Bone Marrow Transplant 2013; 48: 439–445.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Pochon, C., Reppel, L., Halle, P. et al. Cryopreservation as a way to maintain extracorporeal photopheresis regimen for GvHD treatment while circumventing patient temporary inability to undergo apheresis. Bone Marrow Transplant 52, 167–170 (2017). https://doi.org/10.1038/bmt.2016.240
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2016.240